Silver Book Fact

Greater use of clot-busting drug t-PA in ischemic
stroke patients could save the health care system
over $100 million a year.

New Stroke Treatment Likely to Decrease Health Care Costs and Increase Quality of Life. http://www.ninds.nih.gov/news_and_events/press_releases/pressrelease_stroke_treatment_042298.htm. Published 21-Apr-1998

Reference

Title
New Stroke Treatment Likely to Decrease Health Care Costs and Increase Quality of Life
Publication Date
Published 21-Apr-1998
Authors
National Institutes of Health, National Institute of Neurological Disorders and Stroke
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • The development of antioxidants that reduce oxidative damage is underway. One antioxidant that has been found, uric acid, has an even greater protective effect when combined with tPA.  
  • Direct thrombin inhibitor reduced relative risk of venous thromboembolism
    An investigational direct thrombin inhibitor reduced relative risk of venous thromboembolism after total hip replacement surgery by 65.7%—compared to a currently available treatment.  
  • Effectiveness of treating ischemic stroke victims with rt-PA within 3 hours of symptom onset
    A study of the effectiveness of treating ischemic stroke victims with rt-PA within 3 hours of symptom onset found an estimated impact on long-term health outcomes of 564 quality-adjusted life-years saved…  
  • According to the Pharmaceutical Research and Manufacturers of America, 13 medicines are currently in development for stroke.  
  • The rate of hospitalization from heart failure before and after transcatheter mitral valve repair (TMVR) decreases 73% (per patient year) in patients at prohibitive surgical risk.